Approved for 8 EMDRIA Credits

This 4 week course (which begins October 6, 2025) equips EMDR clinicians to integrate ketamine with the 8 EMDR phases, enhancing neuroplasticity and emotional processing. Learn essential neuroscience, safety protocols, and ethical considerations. Explore the emerging roles of psilocybin and MDMA in trauma care. Designed for professionals seeking advanced skills in psychedelic-assisted EMDR therapy.

Presenter: Rotem Brayer, LPC

EMDRIA is not involved with the registration of this event. Please click the Register Here button below to visit the registration website. If you have any questions regarding the training, please use the contact information available on that site.